GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)

NSE:GLAXO Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 15, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	487,669	487,432	329,173	224,319	281,714	244,012
Market Cap Growth	48.08%	48.08%	46.74%	-20.37%	15.45%	15.67%
Enterprise Value	462,551	466,472	313,334	211,499	270,099	237,483
Last Close Price	2878.90	2880.35	1913.82	1273.47	1509.17	1279.61
PE Ratio	52.57	52.55	55.80	36.73	16.62	68.13
PS Ratio	12.52	12.51	9.53	6.90	8.59	8.34
PB Ratio	24.99	24.98	18.52	12.88	10.58	16.51
P/TBV Ratio	25.16	25.15	18.77	13.14	10.72	17.01
P/FCF Ratio	38.49	38.48	59.76	50.96	36.30	45.72
P/OCF Ratio	37.81	37.79	56.56	46.33	34.75	42.22
EV/Sales Ratio	11.88	11.98	9.07	6.50	8.24	8.12
EV/EBITDA Ratio	34.95	35.25	35.58	26.83	36.36	41.42
EV/EBIT Ratio	36.81	37.13	37.35	28.26	38.65	45.71
EV/FCF Ratio	36.51	36.82	56.89	48.05	34.80	44.50
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.02
Debt / EBITDA Ratio	0.01	0.01	0.02	0.02	0.03	0.06
Debt / FCF Ratio	0.01	0.01	0.03	0.04	0.03	0.07
Asset Turnover	1.02	1.02	1.00	0.82	0.85	0.94
Inventory Turnover	2.76	2.76	2.75	2.62	2.55	2.49
Quick Ratio	1.48	1.48	1.45	1.50	1.83	1.02
Current Ratio	1.79	1.79	1.84	1.88	2.18	1.63
Return on Equity (ROE)	49.75%	49.75%	33.53%	27.59%	18.39%	17.42%
Return on Assets (ROA)	20.49%	20.49%	15.24%	11.75%	11.28%	10.39%
Return on Capital (ROIC)	41.80%	41.80%	29.52%	21.07%	20.82%	19.24%
Return on Capital Employed (ROCE)	57.00%	57.00%	41.30%	37.40%	23.80%	29.50%
Earnings Yield	1.90%	1.90%	1.79%	2.72%	6.02%	1.47%
FCF Yield	2.60%	2.60%	1.67%	1.96%	2.76%	2.19%
Dividend Yield	1.88%	-	1.67%	2.51%	1.99%	2.34%
Payout Ratio	80.79%	80.79%	91.80%	249.80%	29.89%	189.04%
Buyback Yield / Dilution	0.01%	0.01%	-	-	-	-
Total Shareholder Return	1.88%	0.01%	1.67%	2.51%	1.99%	2.34%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.